Bohai Pharma Acquires Yantai Tianzheng Pharma, a TCM Maker

Bohai Pharmaceuticals paid $35 million to acquire Yantai Tianzheng Pharmaceutical Co. Both companies produce and distribute modernized TCM products, and both are headquartered in Yantai City. Not only is Yantai Tianzheng profitable, but it is growing at a rapid rate. Bohai said it expects synergies from consolidating the two companies beyond the added revenues/profits the new subsidiary will contribute. More details.... Stock Symbol: (OTCBB: BOPH)     Share this with colleagues: